Detalhe da pesquisa
1.
Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma.
Biol Blood Marrow Transplant
; 23(2): 262-268, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856369
2.
Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning.
Biol Blood Marrow Transplant
; 23(11): 1949-1954, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28729147
3.
Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.
Biol Blood Marrow Transplant
; 23(7): 1151-1157, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28392378
4.
Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies.
Biol Blood Marrow Transplant
; 20(2): 257-63, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24269380
5.
Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis.
JCO Oncol Pract
; 20(3): 351-360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127876
6.
A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma.
Cancer Invest
; 31(3): 172-6, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23406188
7.
A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.
Transplant Cell Ther
; 29(3): 179.e1-179.e10, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577483
8.
Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 18(11): 1664-1676.e1, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22698485
9.
Home-Based Hematopoietic Cell Transplantation in the United States.
Transplant Cell Ther
; 28(4): 207.e1-207.e8, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35066211
10.
Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years.
Transplant Cell Ther
; 28(8): 498.e1-498.e9, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595226
11.
Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.
Biol Blood Marrow Transplant
; 17(6): 867-74, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20868761
12.
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors.
Cancer Invest
; 29(1): 56-61, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21166499
13.
Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation.
Transplant Cell Ther
; 27(9): 784.e1-784.e7, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34146734
14.
Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation.
Bone Marrow Transplant
; 56(1): 137-143, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32624583
15.
Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients.
Transplant Cell Ther
; 27(2): 181.e1-181.e9, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830035
16.
Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell Transplantation.
Transplant Cell Ther
; 27(3): 262.e1-262.e11, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33781532
17.
"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
Biol Blood Marrow Transplant
; 16(1): 70-7, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19733251
18.
Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy.
Cancer Invest
; 28(6): 654-60, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20521909
19.
Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.
JAMA Dermatol
; 155(7): 833-837, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30994873
20.
Mini test dose of intravenous busulfan (busulfex(®)) in allogeneic non-myeloablative stem cell transplantation, followed by liquid chromatography tandem-mass spectrometry.
Cancer Invest
; 30(9): 679-82, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23020519